Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

The incidence of endocervical adenocarcinoma, the second most common cervical cancer
in the world, has been on the rise. While most cervical cancers are squamous cell …

Background Cervical cancer is a leading cause of morbidity and mortality for women
worldwide. Different histopathological cervical cancer subtypes (ie, adenocarcinoma …

Circular RNAs (circRNAs) function as efficient microRNA (miRNA) sponges that regulate
gene expression in the pathogenesis of many human malignancies. However, their roles in …

Primary prevention through the use of human papillomavirus (HPV) vaccination is expected
to impact both cervical intraepithelial neoplasia (CIN) and adenocarcinoma in situ (AIS) …

Background Cervical cancer is a major global health concern, disproportionately affecting
women in developing countries. Cervical cancer has two primary subtypes, squamous cell …

Background Cervical cancer (CC) screening is generally recommended until age 65. The
incidence of CC could be underestimated, particularly in older women, due to a lack of …

Cervical adenocarcinomas are believed to lose estrogen response on the basis of no
expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we …

Background Following the publication of the European consensus statement on standards
for essential colposcopy in 2020, the need for standards relating to more complex and …

Background Although the incidence of cervical adenocarcinoma has consistently increased,
especially among young women, there is no established best means for screening. This …